Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New 5-HT3/5-HT4 antagonists from Synthelabo

Nov. 15, 1996

Anti-H. pylori agents disclosed by Shiseido

Nov. 15, 1996

Natural anti-H. pylori compounds described by Terumo

Nov. 15, 1996

Approval recommended for primary biliary cirrhosis Rx

Nov. 8, 1996

Patent coverage for new HBV treatment licensed to Vion

Nov. 8, 1996

Rabeprazole + amoxicillin for eradication of H. pylori

Nov. 8, 1996

Anti-H. pylori antisense oligonucleotides reported by SCRAS

Nov. 8, 1996

Daiichi discloses CCK-B/gastrin receptor antagonists

Nov. 8, 1996

Vertex solves HCV protease structure

Nov. 1, 1996

Boehringer Ingelheim claims 5-HT4 antagonists for various indications

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026